Analyser av Heliospectra

Heliospectra: Groundwork laid for growth, innovation gains momentum despite soft quarter - Redeye

Redeye has updated its estimates following Heliospectra’s Q1 2025 report.

Heliospectra Q1 2025: Balanced results with some better than expected, some worse - Redeye

Redeye provides its initial take on Heliospectra’s Q1 results, noting that while sales were below expectations, however, the new lower cost ...

Redeye • 25 Apr 12:46

Heliospectra: Commercial expansion with a ready product portfolio – Set for 2025 - Redeye

Redeye updated its estimates and fair value range following Heliospectra’s Q4 2024 report and the fully secured rights issue of SEK 25.

Redeye • 04 Mar 07:47

Heliospectra Q4 2024: Soft results but strengthened market position - Redeye

Redeye provides its initial take on Heliospectra’s Q4 results, noting that while sales were below expectations and costs came in higher, the...

Redeye • 28 Feb 09:53

Heliospectra: Announces a 100% secured rights issue - Redeye

Redeye comments on Heliospectra’s proposed rights issue, fully secured by its main owner, Weland Stål AB, which currently holds 47.

Redeye • 28 Jan 08:26

Heliospectra: All eyes on 2025 - Redeye

Redeye updated its estimates and fair value range following Heliospctras Q3 2024 report, in which sales matched our forecast, but the margin...

Redeye • 30 Oct 2024 07:24

Heliospectra Q3 2024: Weaker gross margin, minor deviations elsewhere - Redeye

Redeye shares its initial comments on Heliospectra's Q3 results, noting that sales and cost base figures were roughly in line with estimates...

Redeye • 25 Oct 2024 11:15

Heliospectra: H1 completed with solid order intake, high expectations for H2 - Redeye

Redeye concludes that Q2 revenues were weaker than expected, derived from short-term delays and order timing.

Redeye • 27 Aug 2024 07:33

Heliospectra Q2 2024: Weaker sales, minor deviations elsewhere - Redeye

Redeye comments on Heliospectra’s Q2 results, noting that sales were weaker than expected due to short-term delays and the timing of orders.

Redeye • 23 Aug 2024 09:26

Heliospectra: Capital Coverage Guarantee of SEK20m - Redeye

Redeye takes a positive stance on Heliospectra’s capital coverage guarantee, which was announced last evening.

Redeye • 29 May 2024 12:13

Heliospectra: Convincing order intake validates product-market fit. - Redeye

Redeye maintains its optimistic outlook post the Q1 2024 report despite slightly lower sales and profitability than expected.

Redeye • 07 May 2024 07:26

Heliospectra Q1 2024: Exceptionally strong order intake - Redeye

Redeye is very encouraged by the strong order intake during the quarter, which came in c70% above our forecast.

Redeye • 03 May 2024 10:06

Heliospectra: Rebound in the Duch market boosts strong growth potential - Redeye

Redeye has revised its estimates in light of Heliospectra’s Q4 2023 report, which was slightly softer than expected regarding sales and orde...

Redeye • 27 Feb 2024 07:21

Heliospectra Q4 2023: Softer than expected - Redeye

Redeye leaves its initial comments on Heliospectras’ Q4 2023 report, in which the figures were slightly softer than expected.

Redeye • 23 Feb 2024 09:34

Heliospectra: Bridge loan of SEK10m - Redeye

Redeye comments on Heliospectra’s bride loan, announced last evening.

Redeye • 22 Nov 2023 11:31

Heliospectra: Continued headwinds on the Dutch market - Redeye

Redeye has revised our estimates in light of Heliospectra’s Q3’23 report, which showed a suppressed top-line and order intake due to macroec...

Redeye • 30 Oct 2023 07:04

Heliospectra: Softer top-line and order intake than expected - Redeye

Redeye concludes that Heliospectra’s Q3 report was somewhat weaker than anticipated in terms of both top-line revenue and order intake.

Redeye • 27 Oct 2023 09:51

Heliospectra: Mixed outlook - Redeye

Redeye provides an update following Heliospectra’s Q2’23 report.

Redeye • 29 Aug 2023 07:37

Heliospectra Q2 2023: First impression - Redeye

Redeye provides its initial take on Heliospectra’s Q2’23 report, noting that sales surpassed our expectations.

Redeye • 25 Aug 2023 09:52

Heliospectra: Transitory quarter with secured growth capital - Redeye

Redeye provides an update following Heliospectra’s Q1’23 report, where an increased gross margin, a well-controlled cost basis, and manageme...

Redeye • 03 May 2023 10:57

Heliospectra Q1 2023: Initial take - Redeye

Redeye provides its initial take on Heliospectra’s Q1’23 report, stating that sales and order intake were weaker than our forecast.

Redeye • 28 Apr 2023 10:17

Heliospectra: Outcome of rights issue - Redeye

Redeye comments on the outcome of Heliospectra's rights issue, which received a subscription rate of c83%.

Redeye • 12 Apr 2023 07:04

Heliospectra: Announces a 77% secured rights issue - Redeye

Redeye comments on Heliospectra’s rights issue, announced earlier this morning.

Redeye • 14 Mar 2023 10:42

Heliospectra Q4 2022: Positive outlook and permanent CEO appointed - Redeye

Redeye provides an update following Heliospectra’s amended Q4'22 report, in which order intake was significantly increased from SEK7.

Redeye • 02 Mar 2023 08:01

Heliospectra Q4 2022 initial take: Ambition to reach break-even by the end of 2023 - Redeye

Redeye provides its initial thoughts on Heliospectra’s fourth-quarter report, which showed net sales of SEK 10.

Redeye • 24 Feb 2023 10:41

Heliospectra- First Smart LED Light Solution Order - Redeye

Redeye endorses today’s news from Heliospectra, an order of USD780,000 from an American AgTech company.

Redeye • 11 Nov 2022 16:36

Heliospectra: Transformation in progress - Redeye

Redeye adjusts our near-term forecasts and our valuation following the Q3 report and the recent share issuance.

Redeye • 25 Oct 2022 09:04

Heliospectra Q3 2022: Encouraging order intake - Redeye

Redeye leaves its initial take on Heliospectra’s Q3 report, which came in with a firm order intake of SEK 9.

Redeye • 21 Oct 2022 14:58

Heliospectra: Preparing for the next step - Redeye

Redeye is making some further adjustments to our near-term forecasts following a rather soft Q2 report.

Redeye • 05 Sep 2022 07:32

Heliospectra Q2: First comment - Redeye

Redeye recognizes that Heliospectra currently is in a phase of transition.

Redeye • 19 Aug 2022 13:15

Heliospectra: Transitional Year - Redeye

Redeye is still optimistic about Heliospectra and the prospects for its new strategic direction as a system supplier within Smart Farming.

Redeye • 26 Apr 2022 07:36

Heliospectra Q1’22: First impression - Redeye

Redeye’s expectations on the Q1 numbers were rather modest as Heliospectra is in a transitional phase following its strategic shift.

Redeye • 22 Apr 2022 12:45

Heliospectra: Strategic Repositioning - Redeye

Redeye has made some revisions to near-term forecasts following Heliospectra’s shift in strategic direction, the Q4 report and other recent ...

Redeye • 28 Feb 2022 07:46

Heliospectra Q4’21: Initial comment - Redeye

Redeye’s expectations were almost in line with Heliospectra’s Q4 numbers, adjusted for non-recurring write-downs.

Redeye • 25 Feb 2022 10:23

Heliospectra: Major growth opportunities ahead - Redeye

Redeye remains positive on the case as we see Heliospectra very well positioned to benefit from the long-term growth trends in the Aghort in...

Redeye • 02 Sep 2021 10:40

Heliospectra: Q2’21: Brief comment - Redeye

Redeye notes that Heliospectra’s Q2 numbers are on par with Q1 and mainly in line with our expectations.

Redeye • 23 Aug 2021 07:25

Börskollen

För dig med koll på börsen